Prehospital Analgesia in Adults Using Inhaled Methoxyflurane Study - Trial NCT06392087
Access comprehensive clinical trial information for NCT06392087 through Pure Global AI's free database. This Phase 4 trial is sponsored by Ottawa Hospital Research Institute and is currently Not yet recruiting. The study focuses on Pain, Acute. Target enrollment is 1800 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ottawa Hospital Research Institute
Timeline & Enrollment
Phase 4
May 01, 2024
Jul 01, 2025
Primary Outcome
Verbal Numeric Pain Score
Summary
This study is about a new pain relief medication called methoxyflurane. Pain from injuries,
 like broken bones, is a big reason people call ambulances. It's important to treat pain well
 because it can make people sick and slow down healing. But often, pain isn't treated enough,
 which can lead to more problems.
 
 Paramedics use different drugs to manage pain, but some are hard to give and need special
 training and equipment. Methoxyflurane is a new option. It's a gas you breathe in through a
 special inhaler. It's been used in Australia and New Zealand for a long time and has shown to
 work quickly and safely for different kinds of pain.
 
 This study wants to see if methoxyflurane works well for people with moderate to severe pain
 from injuries compared to other medicines like Advil, Tylenol and opioids. It's testing if
 methoxyflurane can give fast pain relief and if paramedics find it easy to use. The study
 will help understand if methoxyflurane could be a good option for treating pain in
 ambulances.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06392087
Non-Device Trial